2023 annual financial data
Cadrenal Therapeutics 2023 Operating margin
Cadrenal Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -7,632,843 USD and net income was -8,357,086 USD.
Operating cash flow was -3,530,323 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,632,843 USD
- Net income
- -8,357,086 USD
- Operating cash flow
- -3,530,323 USD